We start with healthy, genetically optimized porcine mesenchymal stem cells (pMSCs) sourced from FDA-grade porcine donors as the basis of our platform.
 
Then, using our patented gene-editing techniques and proprietary bioprocessing and manufacturing techniques, we create an optimized “bespoke” FDA-cleared clinical grade porcine donor.

​

Finally, by harnessing natural biologic development processes, we create a stable master bank of immune-compatible cells nearly identical to any cell type found in the human body. The cells in this bank will be capable of unlimited expansion and differentiation, creating a true platform capable of enabling therapies to treat hundreds of indications.